Castle Biosciences
IPOInnovative Molecular Prognostic and Diagnostic Tests
Public · Friendswood, United States · $51.5M raised
- Headquarters
- Friendswood, Texas
- Employees
- 501–1000
- Business Model
- B2B
- Website
- castlebiosciences.com
- Total Funding
- $51.5M
- Last Round
- $12.0M Series FApr 2019
- Rounds
- 7
- Type
- Public
About
Castle Biosciences is a leading diagnostics company delivering advanced molecular diagnostics and prognostic tests, including genomic profiling for melanoma and other skin cancers, to guide patient care and improve outcomes.
Summary
Castle Biosciences is a Healthcare company based in Friendswood, United States. It has raised $51.5M in total across 7 rounds, most recently a $12.0M Series F round in Apr 2019. Investors include American Cancer Society BrightEdge Fund, Industry Ventures and HealthQuest Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2019
Sign up to see all 8 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
